Pfizer Inc. is a global biopharmaceutical company headquartered in New York, founded in 1849. It discovers, develops, manufactures, and markets prescription medicines and vaccines across therapeutic areas including infectious diseases, oncology, immunology, rare diseases, and internal medicine. Its portfolio spans small‑molecule drugs, biologics, and nucleic acid–based modalities such as mRNA vaccines.
For the chemical and manufacturing value chain, Pfizer operates extensive process development and industrial-scale production capabilities, covering active pharmaceutical ingredient (API) synthesis, fermentation and cell‑culture bioprocessing, sterile injectables, and vaccine manufacturing (including fill‑finish). The company applies process chemistry, analytics, and quality systems to support global supply, and has advanced initiatives in continuous manufacturing and greener chemistry. Pfizer maintains a worldwide network of manufacturing and R&D sites and collaborates with external partners for selected intermediates and finished products. The acquisition of Seagen expanded Pfizer’s position in biologics and antibody–drug conjugates, integrating cytotoxic payloads and linker chemistries with large‑molecule manufacturing.
To provide comprehensive coverage, we aggregate data and news under the name Pfizer, encompassing the following company names, divisions, and related entities:
Pfizer and Seagen.
This list encompasses current and former names, alternate names, and key divisions associated with Pfizer, ensuring you can easily find all relevant information under a single, unified profile.